发明名称 A MIXED COMPLEMENTARY VIRAL VECTOR FOR GENE THERAPY
摘要 <p>Replication able viral vector sequences mixed with replication deficient viral vector(s) delivered in vivo to vector producing cells is disclosed herein. The replication able viral vector has a target cell-activated regulatory sequence or a functional mutation that controls its propagation in the target cells. Alternatively, the vectors can be mutually dependent for replication and physiological effect. The replication deficient vector(s) contains a gene encoding a protein that is expressed in the transduced cells and can induce anticancer responses. The target cells can be carcinomas, sarcomas or other solid tumors, for example. The vectors of this invention can also be utilized to treat other diseases such as restenosis, in which case the target cell can be a vascular smooth muscle cell.</p>
申请公布号 WO2005049094(A1) 申请公布日期 2005.06.02
申请号 WO2004US38179 申请日期 2004.11.15
申请人 ADVANTAGENE, INC.;AGUILAR-CORDOVA, CARLOS, ESTUARDO 发明人 AGUILAR-CORDOVA, CARLOS, ESTUARDO
分类号 A61K35/76;A61K48/00;C12N15/861;(IPC1-7):A61K48/00 主分类号 A61K35/76
代理机构 代理人
主权项
地址